Tempus AI(TEM.US)

Last Updated 19:00:00 ET
longbridge loading

How Beaten-Down Tempus AI Stock Offers a Lottery Ticket for Traders Here

Barchart Option·
US
TEM
-0.56%
Barchart Option·
US
TEM
-0.56%

Tempus AI, Bristol Myers Squibb Expand AI-Driven Clinical Trial Efforts

benzinga_article·
US
TEM
-0.56%
US
BMY
+0.24%
US
PBE
+0.89%
benzinga_article·
US
TEM
-0.56%
US
BMY
+0.24%
US
PBE
+0.89%

Cathie Wood, Ross Gerber Snap Up The Same 10 Stocks — Here's The Unlikely Portfolio Crossover

benzinga_article·
US
LLY
-1.32%
US
NVDA
+2.05%
US
GOOGL
-0.35%
benzinga_article·
US
LLY
-1.32%
US
NVDA
+2.05%
US
GOOGL
-0.35%

Tempus AI Prices $460 Million 0% Convertible Notes Due 2032, Retires Senior Credit Facility

TradingView·
US
TEM
-0.56%
TradingView·
US
TEM
-0.56%

If AI Reshapes Healthcare, These Three Stocks Could Lead

Simplywall·
US
MDT
-1.36%
US
PFE
+0.47%
US
TEM
-0.56%
Simplywall·
US
MDT
-1.36%
US
PFE
+0.47%
US
TEM
-0.56%

Cathie Wood's weekly recap: buys TEM, WGS, and CRWV; sells AMD and RKLB

MSN·
US
RKLB
+4.42%
US
CRWV
+1.53%
US
NTLA
+2.43%
MSN·
US
RKLB
+4.42%
US
CRWV
+1.53%
US
NTLA
+2.43%

Ambry Genetics’ CARE Program® Wins 2026 MedTech Breakthrough Award for “Best Overall Health Informatics Solution”

fidelity·
US
TEM
-0.56%
US
PBE
+0.89%
US
IBB
+1.59%
fidelity·
US
TEM
-0.56%
US
PBE
+0.89%
US
IBB
+1.59%

BTIG Sticks to Their Buy Rating for Tempus AI, Inc. Class A (TEM)

Tip Ranks·
US
TEM
-0.56%
US
BIB
+3.26%
US
BBH
+0.22%
Tip Ranks·
US
TEM
-0.56%
US
BIB
+3.26%
US
BBH
+0.22%

3 Stocks Poised to Disrupt the Healthcare Market by 2030

nasdaq·
US
AXSM
+1.42%
US
RXRX
+1.40%
US
TEM
-0.56%
nasdaq·
US
AXSM
+1.42%
US
RXRX
+1.40%
US
TEM
-0.56%
© 2026 Longbridge｜Disclaimer